British Journal of Cancer - Table of Contents alert Volume 108 Issue 11

TABLE OF CONTENTS Volume 108, Issue 11 (2197-2416) Published online 11 June 2013 In this issue Editorials Report Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Letters to the Editor Also new today Advance online publication Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Take part in our reader survey for a chance to win a MacBook Air As a reader of NPG's clinical and society-owned journals, we invite you to take part in a survey on your use of our journals and their associated websites. Take the survey and be entered into a prize draw for a MacBook Air* *Terms & conditions apply Editorials Top Breast screening remains a controversial issue A L Harris Br J Cancer 2013 108: 2197; advance online publication, June 6, 2013; 10.1038/bjc.2013.259 Full Text The Marmot report: accepting the poisoned chalice M Baum Br J Cancer 2013 108: 2198-2199; advance online publication, June 6, 2013; 10.1038/bjc.2013.258 Full Text Recognising the benefits and harms of breast cancer screening: an opportunity to target improvement C O'Donoghue and L Esserman Br J Cancer 2013 108: 2200-2201; advance online publication, June 6, 2013; 10.1038/bjc.2013.256 Full Text Breast cancer screening: time to target women at risk P Hall and D Easton Br J Cancer 2013 108: 2202-2204; advance online publication, June 6, 2013; 10.1038/bjc.2013.257 Full Text Report Top The benefits and harms of breast cancer screening: an independent review M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson and M Wilcox The Independent UK Panel on Breast Cancer Screening Br J Cancer 2013 108: 2205-2240; advance online publication, June 6, 2013; 10.1038/bjc.2013.177 Full Text Clinical Studies Top Individually tailored screening of breast cancer with genes, tumour phenotypes, clinical attributes, and conventional risk factors Y-Y Wu, M-F Yen, C-P Yu and H-H Chen Br J Cancer 2013 108: 2241-2249; advance online publication, May 14, 2013; 10.1038/bjc.2013.202 Abstract | Full Text A decision impact, decision conflict and economic assessment of routine Oncotype DX testing of 146 women with node-negative or pNImi, ER-positive breast cancer in the UK S Holt, G Bertelli, I Humphreys, W Valentine, S Durrani, D Pudney, M Rolles, M Moe, S Khawaja, Y Sharaiha, E Brinkworth, S Whelan, S Jones, H Bennett and C J Phillips Br J Cancer 2013 108: 2250-2258; advance online publication, May 21, 2013; 10.1038/bjc.2013.207 Abstract | Full Text Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series F Zagouri, T N Sergentanis, V Koutoulidis, C Sparber, G G Steger, P Dubsky, G C Zografos, T Psaltopoulou, M Gnant, M-A Dimopoulos and R Bartsch Br J Cancer 2013 108: 2259-2263; advance online publication, May 30, 2013; 10.1038/bjc.2013.255 Abstract | Full Text Patients’ and oncologists’ views on the treatment and care of advanced ovarian cancer in the UK: results from the ADVOCATE study V Jenkins, S Catt, S Banerjee, C Gourley, A Montes, I Solis-Trapala, K Monson and L Fallowfield Br J Cancer 2013 108: 2264-2271; advance online publication, May 7, 2013; 10.1038/bjc.2013.223 Abstract | Full Text Translational Therapeutics Top Telomerase reverse transcriptase inhibition stimulates cyclooxygenase 2 expression in cancer cells and synergizes with celecoxib to exert anti-cancer effects T Liu, X Liang, B Li, M Björkholm, J Jia and D Xu Br J Cancer 2013 108: 2272-2280; advance online publication, May 16, 2013; 10.1038/bjc.2013.208 Abstract | Full Text Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice D Chandra, A Jahangir, W Quispe-Tintaya, M H Einstein and C Gravekamp Br J Cancer 2013 108: 2281-2290; advance online publication, May 2, 2013; 10.1038/bjc.2013.206 Abstract | Full Text Directing HER4 mRNA expression towards the CYT2 isoform by antisense oligonucleotide decreases growth of breast cancer cells in vitro and in vivo T O Nielsen, S Sorensen, F Dagnæs-Hansen, J Kjems and B S Sorensen Br J Cancer 2013 108: 2291-2298; advance online publication, May 21, 2013; 10.1038/bjc.2013.247 Abstract | Full Text Molecular Diagnostics Top A step-by-step guide to the systematic review and meta-analysis of diagnostic and prognostic test accuracy evaluations Z Liu, Z Yao, C Li, X Liu, H Chen and C Gao Br J Cancer 2013 108: 2299-2303; advance online publication, May 21, 2013; 10.1038/bjc.2013.185 Abstract | Full Text Proto-oncogenic isoform A2 of eukaryotic translation elongation factor eEF1 is a target of miR-663 and miR-744 A Vislovukh, G Kratassiouk, E Porto, N Gralievska, C Beldiman, G Pinna, A El'skaya, A Harel-Bellan, B Negrutskii and I Groisman Br J Cancer 2013 108: 2304-2311; advance online publication, May 21, 2013; 10.1038/bjc.2013.243 Abstract | Full Text Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma S Yoshimine, E Kikuchi, T Kosaka, S Mikami, A Miyajima, Y Okada and M Oya Br J Cancer 2013 108: 2312-2320; advance online publication, May 14, 2013; 10.1038/bjc.2013.216 Abstract | Full Text Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer K Boman, A H Larsson, U Segersten, E Kuteeva, H Johannesson, B Nodin, J Eberhard, M Uhlén, P-U Malmström and K Jirström Br J Cancer 2013 108: 2321-2328; advance online publication, May 7, 2013; 10.1038/bjc.2013.215 Abstract | Full Text Epidemiology Top Features of cancer in teenagers and young adults in primary care: a population-based nested case–control study R M Dommett, M T Redaniel, M C G Stevens, W Hamilton and R M Martin Br J Cancer 2013 108: 2329-2333; advance online publication, April 25, 2013; 10.1038/bjc.2013.191 Abstract | Full Text Allergy and acute leukaemia in children with Down syndrome: a population study. Report from the Mexican inter-institutional group for the identification of the causes of childhood leukaemia J C Núñez-Enríquez, A Fajardo-Gutiérrez, E P Buchán-Durán, R Bernáldez-Ríos, A Medina-Sansón, E Jiménez-Hernández, R Amador-Sanchez, J G Peñaloza-Gonzalez, R Paredes-Aguilera, F J Alvarez-Rodriguez, V Bolea-Murga, J de Diego Flores-Chapa, J Flores-Lujano, V C Bekker-Mendez, R Rivera-Luna, M del Carmen Rodriguez-Zepeda, A Rangel-López, E M Dorantes-Acosta, N Núñez-Villegas, M M Velazquez-Aviña, J R Torres-Nava, N C Reyes-Zepeda, R Cárdenas-Cardos, L V Flores-Villegas, A Martinez-Avalos, F Salamanca-Gómez, C Gorodezky, J Arellano-Galindo and J M Mejía-Aranguré Br J Cancer 2013 108: 2334-2338; advance online publication, May 21, 2013; 10.1038/bjc.2013.237 Abstract | Full Text Socioeconomic variation in survival from childhood leukaemia in northern England, 1968–2010 K Njoku, N Basta, K D Mann, R J Q McNally and M S Pearce Br J Cancer 2013 108: 2339-2345; advance online publication, May 7, 2013; 10.1038/bjc.2013.222 Abstract | Full Text Patterns of exposure to infectious diseases and social contacts in early life and risk of brain tumours in children and adolescents: an International Case–Control Study (CEFALO) T V Andersen, L S Schmidt, A H Poulsen, M Feychting, M Röösli, T Tynes, D Aydin, M Prochazka, B Lannering, L Klæboe, T Eggen, C E Kuehni, K Schmiegelow and J Schüz Br J Cancer 2013 108: 2346-2353; advance online publication, May 7, 2013; 10.1038/bjc.2013.201 Abstract | Full Text Model-based patterns in prostate cancer mortality worldwide F Fontes, M Severo, C Castro, S Lourenço, S Gomes, F Botelho, C La Vecchia and N Lunet Br J Cancer 2013 108: 2354-2366; advance online publication, May 9, 2013; 10.1038/bjc.2013.217 Abstract | Full Text Descriptive epidemiology of ependymal tumours in the United States J L Villano, C K Parker and T A Dolecek Br J Cancer 2013 108: 2367-2371; advance online publication, May 9, 2013; 10.1038/bjc.2013.221 Abstract | Full Text Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer risk J Wang, X Wu, A Kamat, H Barton Grossman, C P Dinney and J Lin Br J Cancer 2013 108: 2372-2380; advance online publication, April 30, 2013; 10.1038/bjc.2013.190 Abstract | Full Text Coffee consumption and the risk of prostate cancer: the Ohsaki Cohort Study Q Li, M Kakizaki, Y Sugawara, Y Tomata, T Watanabe, Y Nishino and I Tsuji Br J Cancer 2013 108: 2381-2389; advance online publication, May 14, 2013; 10.1038/bjc.2013.238 Abstract | Full Text Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study F Murphy, M E Kroll, K Pirie, G Reeves, J Green and V Beral on behalf of the Million Women Study Collaborators Br J Cancer 2013 108: 2390-2398; advance online publication, May 2, 2013; 10.1038/bjc.2013.159 Abstract | Full Text Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors R Cooke, M E Jones, D Cunningham, S J Falk, D Gilson, B W Hancock, S J Harris, A Horwich, P J Hoskin, T Illidge, D C Linch, T A Lister, H H Lucraft, J A Radford, A M Stevens, I Syndikus, M V Williams, the England and Wales Hodgkin Lymphoma Follow-up Group and A J Swerdlow Br J Cancer 2013 108: 2399-2406; advance online publication, May 7, 2013; 10.1038/bjc.2013.219 Abstract | Full Text Is a cancer diagnosis a trigger for health behaviour change? Findings from a prospective, population-based study K Williams, A Steptoe and J Wardle Br J Cancer 2013 108: 2407-2412; advance online publication, May 21, 2013; 10.1038/bjc.2013.254 Abstract | Full Text Letters to the Editor Top Mortality benefits and overdiagnosis estimates for women attending breast screening N Ormiston-Smith, H Scowcroft and C S Thomson Br J Cancer 2013 108: 2413-2414; advance online publication, June 6, 2013; 10.1038/bjc.2013.260 Full Text Does age really matter in the choice of treatment for bladder cancer? F Dal Moro, A Rossi and F Zattoni Br J Cancer 2013 108: 2415-2416; advance online publication, May 14, 2013; 10.1038/bjc.2013.239 Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.